No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study

Blood Adv. 2023 Sep 12;7(17):4869-4873. doi: 10.1182/bloodadvances.2023010480.

Emma E Geerdes¹, Müjde Durmaz^{1

2}, Pieternella J Lugtenburg³, Martine E D Chamuleau⁴, Otto Visser⁵, Djamila E Issa⁶, Rolf E Brouwer⁷, Eduardus F M Posthuma^{7

8}, Josée M Zijlstra⁴, Marie José Kersten², Avinash G Dinmohamed^{1

2

4

9}

¹ Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
² Amsterdam University Medical Center, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
³ Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁴ Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
⁵ Department of Registration, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
⁶ Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
⁷ Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.
⁸ Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
⁹ Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

No abstract available

MeSH terms